Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 3, 2013

View Archived Issues

Researchers present preclinical results for ML-297

Characterization and development of a potent inhibitor of cholesterol biosynthesis

Novel podophyllotoxin derivatives with significant antitumor activity presented

ACT-001 demonstrates efficacy and high oral bioavailability in vivo

Trial of gene therapy for Sanfilippo B syndrome begins

Suven presents a novel 5-HT6 receptor antagonist for the treatment of AD

New alpha-type CGRP receptor antagonists disclosed by Merck & Co.

Canadian group designs novel heteromultimer constructs for cancer

Healios and DSP sign Japanese joint development agreement for iPS-derived RPE cells

Vital Therapies enrolls first subject in Australia in phase III VTI-208 trial

FDA extends PDUFA date for Alprolix BLA

First patient treated in phase I/II HGB-205 study

FDA accepts Zalviso NDA for filing

Isis Pharmaceuticals earns milestone payment from GSK for ISIS-TTRRx

Actelion provides update on the DUAL program

NeurOp divulges novel NMDA receptor antagonists

Immunotherapeutic 3M-052 shows oncolytic potential

EMD Serono launches TocopheRx, a new spin-off focused on infertility treatment

Novel immunogenic peptide compositions presented by French group

ProJect Pharmaceutics signs agreement to develop new formulation of IMX-101

Novel CDK inhibitor unaffected by transporter-dependent drug resistance

Phase II all-oral combination study of simeprevir, TMC-647055 and samatasvir begins

PharmAthene terminates merger agreement with Theraclone Sciences

Baxter submits amended BLA for HyQvia

Forest Laboratories to acquire U.S. rights to Saphris

FDA grants orphan drug designation to Conatus' emricasan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...